170504 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
METHOD OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#602IMMUNE REACTIVITY TO HER-2/NEU PROTEIN FOR DIAGNOSIS AND TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/NEU ONCOGENE IS ASSOCIATED
#603High-throughput high-information content label-free cell biology screening methods
#604PLGF, FLT1 AND ENDOGLIN FOR DIAGNOSING ANGIOGENIC STATUS IN CORONARY ARTERY DISEASE
#605METHOD OF IDENTIFICATION OF CELLS THAT SHOW SENSITIVITY TO MODULATION OF SIGNALINGH MEDIATED BY FIBROBLAST GROWTH FACTOR RECEPTOR OR A VARIANT THEREOF
#606DRG11-Responsive (DRAGON) Gene Family
#607ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY
#608Circulating tumor cell assay
#609Fluorescence based reporter construct for the direct detection of TGF-beta receptor activation and modulators thereof
#610Antisense RNA for treating cancer and inhibition of metastasis and vectors for antisense sequestration
#611Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
#612MUTANT ANTIBODIES WITH HIGH AFFINITY FOR EGFR
#613Identification of Biomarkers Predictive of Dasatinib Effects in Cancer Cells
#614METHOD FOR MEASURING PLASMA LEVELS OF LONG PENTRAXIN PTX3
#615Method of predicting metastasis of oral cavity cancer into cervical lymph node and diagnosis kit to be used in the prediction
#616Method for diagnosing cancers expressing the HER2 receptor or its truncated variants
#617Biosensor antibody functional mapping
#618Compounds Modulating Vegf Receptor and Uses Thereof
#619Sparc and methods of use thereof
#620Diagnostic tests and personalized treatment regimes for cancer stem cells
#621Antitumor agent for undifferentiated gastric cancer
#622NONAPOPTOTIC FORMS OF CELL DEATH AND METHODS OF MODULATION
#623Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#624Method for establishing the sensitivity of tumours to capecitabin and test kit
#625METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
#626INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE
#627Dual-target biosensor cell assays
#628TGR3-Like Protein Receptor
#629Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
#630Diagnostic And Therapeutic Uses Of Augmenter Of Liver Regeneration In Inflammatory Conditions
#631EGFR AND KRAS MUTATIONS
#632Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
#633Treatment of cancers expressing p95 ErbB2
#634sVEGFR-2 and its role in lymphangiogenesis modulation
#635FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
#636Determination of sFlt-1:angiogenic factor complex
#637NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS
#638Detection of circulating endothelial cells
#639Methods for inhibiting VEGF-D
#640INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE
#641Measuring receptor homodimerization
#642Methods for tissue analysis
#643Methods for a predictive diagnostic test for tamoxifen
#644Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases
#645Methods of donor specific crossmatching
#646Epidermal Growth Factor Receptor Polypeptides and Antibodies
#647Methods of selecting epidermal growth factor receptor (EGFR) binding agents
#648FGFR AGONISTS
#649Cellular upregulation of VEGF receptor expression using nanofibrillar articles
#650T. Cruzi-derived neurotrophic agents and methods of use therefor
#651MARKERS FOR PREECLAMPSIA
#652Methods for early diagnosing of an increased risk of preeclampsia
#653Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#654Modular point-of-care devices, systems, and uses thereof
#655Method of identifying transmembrane protein-interacting compounds
#656Diagnostic methods
#657INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE
#658Soluble ErbB3 method of detection
#659EGFR ANTIGEN-BINDING MOLECULES AND USES THEREOF
#660Detecting and Profiling Molecular Complexes
#661Bispecific single chain Fv antibody molecules and methods of use thereof
#662LYMPHATIC ENDOTHELIAL CELLS MATERIALS AND METHODS
#663Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
#664Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
#665Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders
#666Soluble ErbB3 receptor isoforms
#667Fetuin-A as a biomarker for multiple sclerosis
#668Mer Diagnostic and Therapeutic Agents
#669Soluble ErbB3 and treatment of cancer
#670Methods for inhibiting heregulin and treating cancer
#671Soluble ErbB3 receptor isoforms
#672Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
#673BREAST CANCER ERADICATION PROGRAM
#674Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#675Mutations in ErbB2 associated with cancerous phenotypes
#676Preventing airway mucus production by administration of EGF-R antagonists
#677Preventing airway mucus production by administration of EGF-R antagonists
#678Methods for diagnosing and treating breast cancer based on a HER/ER ratio
#679Autocrine Growth Factor Receptors and Methods
#680Fragments of antibodies to epidermal growth factor receptor and methods of their use
#681Isolated Nucleic Acids, Vectors and Host Cells Encoding ErbB3 Antibodies
#682MN/CA IX and EGFR pathway inhibition
#683Anti-ErbB2 antibodies
#684Human cancer stem cell culture compositions comprising Erbb2 variants and methods of use thereof
#685Immune reactivity to HER-2/protein for diagnosis and treatment of malignancies in which the HER-2/oncogene is associated
#686Method and Apparatus for Diagnosing Pre-eclampsia
#687Human DRG11-responsive axonal guidance and outgrowth of neurite (dragon) proteins and variants thereof
#688DOMINANT NEGATIVE LIGAND DRUG DISCOVERY SYSTEM
#689Neurotransmission disorders
#690Methods for tissue analysis
#691Methods of screening based on the EGF receptor crystal structure
#692Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or α1 type IV collagen
#693System and method for determining individualized medical intervention for a disease state
#694Methods Of Treating Demyelinating Disorders
#695In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (BMPS) and/or blood-derived circulating precursor cells (BDPS)
#696Preventing airway mucus production by administration of EGF-R antagonists
#697Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof
#698Method for screening substances capable of promoting oligomerization of receptor protein molecules
#699Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof
#700Use of soluble FLT-1 and its fragments in cardiovascular conditions
#701Binding polypeptides and uses thereof
#702Methods for prediction and prognosis of cancer, and monitoring cancer therapy
#703Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
#704Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-α
#705Predictors Of Patient Response To Treatment With EGFR Inhibitors
#706ISOLATED NUCLEIC ACIDS, VECTORS AND HOST CELLS ENCODING ErbB3 ANTIBODIES
#707In vitro method to detect bladder transitional cell carcinoma
#708VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
#709Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#710In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto
#711Biomarkers in cancer
#712Quantitative assays for PDGFR-beta in body fluids
#713Devices and methods for enrichment and alteration of circulating tumor cells and other particles
#714Epidermal growth factor receptor polypeptides and antibodies
#715Immunoassay of phosphorylated proteins
#716High affinity human antibodies to tumor antigens
#717Erbb receptor methods and kits for monitoring chemotherapy resistance
#718Lymphatic endothelial cells materials and methods
#719Methods and compositions for the modulation of immune responses and cancer diseases
#720Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
#721Protein scaffolds and uses thereof
#722Treatment of cancers expressing p95 erbb2
#723Detection of activation of endothelial cells as surrogate marker for angiogenesis
#724Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
#725Diagnosis of preeclampsia
#726Method for screening substances capable of promoting oligomerization of receptor protein molecules
#727Tissue analysis and kits therefor
#728Modulation of growth hormone receptor expression and insulin-like growth factor expression
#729Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics
#730Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
#731Eph receptor tumor biomarkers
#732Gpcs as modifiers of the irrtk p21 pathways and methods of use
#733Methods to diagnose and treat lung cancer
#734Bispecific single chain Fv antibody molecules and methods of use thereof
#735Methods for the treatment or prevention of obesity
#736Compounds and therapies for the prevention of vascular and non-vascular pathologies
#737Methods of diagnosing and treating complications of pregnancy
#738DRG11-responsive (DRAGON) gene family
#739Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
#740Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
#741Method of identifying transmembrane protein-interacting compounds
#742Methods and compositions for activating VEGF-D and VEGF-C
#743Antibodies to insulin-like growth factor I receptor
#744Compositions and methods for modulating signaling mediated by IGF-1 receptor and erbB receptors
#745EGFR mutations
#746Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#747Erythropoietin and erythropoietin receptor expression in human cancer
#748Antibodies to insulin-like growth factor I receptor
#749Methods of donor specific crossmatching
#750Use of an epitope of vascular endothelial growth factor receptor KDR/Flk-1
#751Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
#752VEGF receptor antagonists
#753Compounds for eliciting or enhancing immune reactivity to HER-2/protein for prevention or treatment of malignancies in which the HER-2/oncogene is associated
#754Method for screening FGFR-4 agonists
#755Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies
#756Method for diagnosing increased risk of preeclampsia
#757Immobilized N-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
#758Methods for identifying alpha PDGFR agonists and antagonists
#759Cell line comprising vector encoding truncated FLK-1 receptor
#760Tissue analysis and kits therefor
#761Measuring receptor homodimerization
#762Novel proteins with targeted binding
#763Detecting and profiling molecular complexes
#764Method of screening endothelial cells for angiogenic capability
#765VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
#766Uses of an endothelial cell receptor
#767Methods for determining risk of developing cervical cancer
#768Prognostic evaluation of cancer
#769Compounds and therapies for the prevention of vascular and non-vascular pathologies
#770Composition comprising aflibercept and a variant thereof, and related methods and uses